GeneBioTech Co. ,Ltd (KOSDAQ:086060)
South Korea
· Delayed Price · Currency is KRW 3,160.00
+5.00 (0.16%)
At close: Mar 28, 2025, 3:30 PM KST
GeneBioTech Co. ,Ltd Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | 2,865 | 2,591 | 1,523 | -484.4 | -2,341 | Upgrade
|
| Depreciation & Amortization | 1,368 | 1,338 | 1,286 | 1,244 | 2,047 | Upgrade
|
| Loss (Gain) From Sale of Assets | -122.26 | -20.69 | 0 | 5.88 | 1,194 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | 589.54 | - | - | - | Upgrade
|
| Provision & Write-off of Bad Debts | -96.12 | -27.83 | 36.83 | 31.96 | 230.15 | Upgrade
|
| Other Operating Activities | 797.55 | 1,066 | 284.17 | 155.03 | 1,240 | Upgrade
|
| Change in Accounts Receivable | -1,662 | 2,464 | -3,955 | -3,602 | 469.97 | Upgrade
|
| Change in Inventory | -2,239 | 650.04 | -1,806 | -3,390 | -189.74 | Upgrade
|
| Change in Accounts Payable | -193.85 | -336.71 | -813.24 | 3,088 | 348.46 | Upgrade
|
| Change in Unearned Revenue | - | - | - | -1.96 | -0.13 | Upgrade
|
| Change in Income Taxes | - | -15.88 | 118.62 | 136.36 | -61.06 | Upgrade
|
| Change in Other Net Operating Assets | -1,182 | -929.93 | -353.49 | 103.98 | -445.8 | Upgrade
|
| Operating Cash Flow | -463.87 | 7,369 | -3,679 | -2,713 | 2,492 | Upgrade
|
| Capital Expenditures | -1,100 | -530.02 | -1,155 | -3,102 | -4,386 | Upgrade
|
| Sale of Property, Plant & Equipment | 224.62 | 23.14 | - | 6.36 | 59.63 | Upgrade
|
| Cash Acquisitions | - | - | - | - | -208.08 | Upgrade
|
| Sale (Purchase) of Intangibles | -82.71 | -236.9 | -18.91 | -12.28 | 91.4 | Upgrade
|
| Investment in Securities | 124.03 | -4,608 | 1,685 | 8,397 | 3,245 | Upgrade
|
| Other Investing Activities | 16.96 | -31.71 | -5.9 | 211.41 | 371.36 | Upgrade
|
| Investing Cash Flow | -1,030 | -5,326 | 649.96 | 5,745 | -703.78 | Upgrade
|
| Short-Term Debt Issued | 16,673 | 12,398 | 17,015 | 14,232 | 11,282 | Upgrade
|
| Long-Term Debt Issued | 1,830 | 2,200 | 1,375 | 1,000 | 155.22 | Upgrade
|
| Total Debt Issued | 18,503 | 14,598 | 18,390 | 15,232 | 11,437 | Upgrade
|
| Short-Term Debt Repaid | -13,841 | -14,013 | -15,237 | -10,623 | -9,454 | Upgrade
|
| Long-Term Debt Repaid | -1,686 | -1,298 | -117.76 | -2,984 | -224.57 | Upgrade
|
| Total Debt Repaid | -15,527 | -15,311 | -15,355 | -13,608 | -9,679 | Upgrade
|
| Net Debt Issued (Repaid) | 2,976 | -712.61 | 3,035 | 1,625 | 1,759 | Upgrade
|
| Dividends Paid | - | - | - | -258.32 | -258.32 | Upgrade
|
| Other Financing Activities | - | 0 | - | -5,820 | -94.08 | Upgrade
|
| Financing Cash Flow | 2,976 | -712.61 | 3,035 | -4,453 | 1,406 | Upgrade
|
| Foreign Exchange Rate Adjustments | 46.92 | -9.59 | -6 | 57.42 | -23.85 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | -0 | - | - | -0 | Upgrade
|
| Net Cash Flow | 1,529 | 1,321 | -0.08 | -1,364 | 3,170 | Upgrade
|
| Free Cash Flow | -1,564 | 6,838 | -4,834 | -5,816 | -1,895 | Upgrade
|
| Free Cash Flow Margin | -1.89% | 8.60% | -5.84% | -9.26% | -3.21% | Upgrade
|
| Free Cash Flow Per Share | -181.81 | 794.31 | -561.41 | -675.39 | -220.06 | Upgrade
|
| Cash Interest Paid | 621.87 | 177.07 | 181.39 | 36.97 | 94.08 | Upgrade
|
| Cash Income Tax Paid | 418.01 | 216.78 | -141.85 | 386.84 | 314.69 | Upgrade
|
| Levered Free Cash Flow | -3,064 | 5,514 | -5,633 | -5,825 | -6,058 | Upgrade
|
| Unlevered Free Cash Flow | -2,662 | 5,877 | -5,460 | -5,730 | -6,058 | Upgrade
|
| Change in Net Working Capital | 5,249 | -2,823 | 6,545 | 3,577 | 3,125 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.